MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle

Carcinogenesis

Volumn 33, Issue 8, 2012, Pages 1522-1530

  Yang, I Ping ^a,b   Tsai, Hsiang Lin ^c,d,e   Hou, Ming Feng ^d,e   Chen, Ku Chung ^a   Tsai, Pei Chien ^a   Huang, Szu Wei ^a   Chou, Wen Wen ^a,c   Wang, Jaw Yuan ^a,c,d,e   Juo, Suh Hang Hank ^a,e  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b SHU ZEN COLLEGE OF MEDICINE AND MANAGEMENT   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d Department of Otorhinolaryngology Head and Neck Surgery   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MICRORNA; MICRORNA 93; PROTEIN; PROTEIN CCNB1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER RECURRENCE; CANCER RELAPSE; CELL CYCLE REGULATION; CELL DEATH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT;

AGED; BASE SEQUENCE; CELL CYCLE; COHORT STUDIES; COLORECTAL NEOPLASMS; DNA PRIMERS; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; RECURRENCE;

EID: 84865326680     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs166     Document Type: Article

References (48)

1. Slaby, O. et al. (2009) MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol. Cancer, 8, 102.
2. Cho, W.C. et al. (2010) MicroRNAs in cancer - from research to therapy. Biochim. Biophys. Acta, 1805, 209-217.
3. Cho, W.C. et al. (2010) MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol., 42, 1273-1281.
4. Motoyama, K. et al. (2009) Over- and under-expressed microRNAs in human colorectal cancer. Int. J. Oncol., 34, 1069-1075.
5. Schetter, A.J. et al. (2011) Alterations of microRNAs contribute to colon carcinogenesis. Semin. Oncol., 38, 734-742.
6. Albulescu, R. et al. (2011) Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers. Expert Rev. Mol. Diagn., 11, 101-120.
7. Hui, A. et al. (2011) Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. BMC Cancer, 11, 500.
8. Edge, S.B. et al. (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol., 17, 1471-1474.
9. Becker, H. et al. (1995) [Surgery of colorectal carcinoma]. Praxis (Bern 1994), 84, 1371-1372.
10. Tsai, H.L. et al. (2009) Predicting factors of postoperative relapse in T2-4N0M0 colorectal cancer patients via harvesting a minimum of 12 lymph nodes. Int. J. Colorectal Dis., 24, 177-183.
11. Longo, W.E. et al. (2002) The preoperative assessment and postoperative surveillance of patients with colon and rectal cancer. Surg. Clin. North Am., 82, 1091-1108.
12. Kobayashi, H. et al. (2007) Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery, 141, 67-75.
13. Vickers, A.J. et al. (2006) Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence? Cancer, 106, 576-580.
14. Wang, Y. et al. (2004) Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J. Clin. Oncol., 22, 1564-1571.
15. Weitz, J. et al. (2005) Colorectal cancer. Lancet, 365, 153-165.
16. Cho, W.C. (2011) Epigenetic alteration of microRNAs in feces of colorectal cancer and its clinical significance. Expert Rev. Mol. Diagn., 11, 691-694.
17. Cho, W. (2011) (ed) MicroRNAs in Cancer Translational Research. Springer, Berlin, Germany.
18. Cao, D. et al. (2009) Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications. BMC Cancer, 9, 432.
19. Schetter, A.J. et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299, 425-436.
20. Tsai, H.L. et al. (2009) Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection. J. Surg. Oncol., 100, 736-743.
21. Hwang, C.C. et al. (2010) S100B protein expressions as an independent predictor of early relapse in UICC stages II and III colon cancer patients after curative resection. Ann. Surg. Oncol., 18, 139-145.
22. Chang, K.H. et al. (2010) MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer, 10, 173.
23. Wu, T.J. et al. (2006)Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis. World J. Surg., 30, 391-398; discussion 399.
24. Devesa, S.S. et al. (2005) International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int. J. Cancer, 117, 294-299.
25. Burfeind, P. et al. (1996) Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc. Natl. Acad. Sci. U.S.A., 93, 7263-7268.
26. Long, J. et al. (2010) Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J. Biol. Chem., 285, 23457-23465.
27. Petrocca, F. et al. (2008) E2F1-regulated microRNAs impair TGFbetadependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell, 13, 272-286.
28. Kim, Y.K. et al. (2009) Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res., 37, 1672-1681.
29. Wang, S. et al. (2008) Inhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interference. Neoplasia, 10, 399-407.
30. Besson, A. et al. (2004) Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors? Nat. Rev. Cancer, 4, 948-955.
31. Xia, W. et al. (2010) MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells. Mol. Cell Biochem., 344, 261-266.
32. Tripathi, R. et al. (2011)Messenger RNA and microRNA profiling during early mouse EB formation. Gene Expr. Patterns, 11, 334-344.
33. Wulczyn, F.G. et al. (2007) Post-transcriptional regulation of the let-7 microRNA during neural cell specification. FASEB J., 21, 415-426.
34. Guan, H. et al. (2005) A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model. Clin. Cancer Res., 11, 2662-2669.
35. Ohta, Y. et al. (1996) Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin. Cancer Res., 2, 1411-1416.
36. Kranz, A. et al. (1999) Molecular mediators of tumor angiogenesis: enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer. Int. J. Cancer, 84, 293-298.
37. Ferrer, F.A. et al. (1999) Expression of vascular endothelial growth factor receptors in human prostate cancer. Urology, 54, 567-572.
38. Tian, X. et al. (2001) Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803. Biochem. Biophys. Res. Commun., 286, 505-512.
39. Fang, L. et al. (2010) MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8. Oncogene., 30, 806-821.
40. Porrello, E.R. et al. (2011) MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes. Circ. Res., 109, 670-679.
41. Carney, D.A. et al. (2005) Genetics and molecular biology of chronic lymphocytic leukemia. Curr. Treat Options Oncol., 6, 215-225.
42. Stadler, B. et al. (2010) Characterization of microRNAs involved in embryonic stem cell states. Stem Cells Dev., 19, 935-950.
43. Nam, E.J. et al. (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clin. Cancer Res., 14, 2690-2695.
44. Li, Y. et al. (2009) Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci., 100, 1234-1242.
45. Diaz, R. et al. (2008) Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosomes Cancer, 47, 794-802.
46. Altuvia, Y. et al. (2005) Clustering and conservation patterns of human microRNAs. Nucleic Acids Res., 33, 2697-2706.
47. Ivanovska, I. et al. (2008) MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell Biol., 28, 2167-2174.
48. Foshay, K.M. et al. (2009) miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation. Dev. Biol., 326, 431-443.